55.00 USD – 80.00 USD
Andarine (GTx-007, S-4) is an investigational SARM developed to treat conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy.
Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs, but even though it may be weakest in anabolic activity, it is one of the most androgenic, being 1/3 as strong as testosterone at binding to the androgen receptor.
Unlike many androgens, Andarine does not convert to dihydrotestosterone (DHT) and it does not aromatize (covert to estrogen). This makes it more appealing compared to other androgenic compounds on a functional basis as negative DHT and Estradiol effects cannot occur with its use. Andarine has been shown to block DHT from binding to the prostate receptor sites. Andarine has a half-life of 4 hours.
*Everything in this description is publicly available and is intended for informational purposes only. For more detailed information, please conduct your own research and consult with experts in the field.
|Dimensions||4 × 1.25 × 1.25 cm|
20mg/ml in 30ml bottle, 30mg/ml in 30ml bottle